Neuroprotective effects of sigma-1 receptor agonists against beta-amyloid-induced toxicity

NeuroReport

Volumn 16, Issue 11, 2005, Pages 1223-1226

  Marrazzo, Agostino ^a   Caraci, Filippo ^a   Salinaro, Elisa Trovato ^a   Su, Tsung Ping ^c   Copani, Agata ^a,b   Ronsisvalle, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

amyloid; 1 receptor agonists; Neuronal apoptosis

Indexed keywords

1 PHENYLCYCLOHEXANECARBOXYLIC ACID 2 MORPHOLINOETHYL ESTER; 2 (4 MORPHOLINETHYL)1 PHENYLCYCLOHEXANECARBOXYLATE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMYLOID BETA PROTEIN[25-35]; CARBOXYLIC ACID DERIVATIVE; DIZOCILPINE; METHYL 2 [1 ADAMANTYL(METHYL)AMINO] METHYL 1 PHENYLCYCLOPROPANECARBOXYLATE; MR 22; OPIATE AGONIST; OPIATE ANTAGONIST; PROTEIN BAX; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG ANTAGONISM; DRUG SYNTHESIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; ANISOLES; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EMBRYO; EXCITATORY AMINO ACID ANTAGONISTS; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PROPYLAMINES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, SIGMA;

EID: 23044437134     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200508010-00018     Document Type: Article

References (21)

1. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-356.
2. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW et al. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 1993; 90:7951-7955.
3. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995; 133:225-230.
4. Caricasole A, Copani A, Caraci F, Aronica E, Rozemuller AJ, Caruso A et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain. J Neurosci 2004; 24:6021-6027.
5. Guitart X, Codony X, Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology 2004; 174:301-319.
6. 1 receptor agonist PRE-084 against the spatial learning deficits in aged rats. Eur J Pharmacol 2001; 431:223-227.
7. 1 (σ1) receptor agonists and neurosteroids attenuate β25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience 1998; 83:413-428.
8. 1 (σ) receptor agonists in beta(25-35)-amyloid peptide-treated mice. Behav Brain Res 2002; 134:239-247.
9. Kume T, Nishikawa H, Taguchi R, Hashino A, Katsuki H, Kaneko S et al. Antagonism of NMDA receptors by sigma receptor ligands attenuates chemical ischemia-induced neuronal death in vitro. Eur J Pharmacol 2002; 455:91-100.
10. Takahashi H, Kirsch JR, Hashimoto K, London ED, Koehler RC et al. PPBP [4-phenyl-1-(4-phenylbutyl) piperidine] decreases brain injury after transient focal ischemia in rats. Stroke 1996; 27:2120-2123.
11. Copani A, Condorelli F, Caruso A, Vancheri C, Sala A, Giuffrida Stella AM et al. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J 1999; 13:2225-2234.
12. Marrazzo A, Prezzavento O, Pappalardo MS, Bousquet E, Iadanza M, Pike VW et al. Synthesis of (+)- and(-)-cis-2-[(1-adamantylamino)-methyl]-1 phenylcyclopropane derivatives as high affinity probes for sigma1 and sigma2 binding sites. Farmaco 2002; 57:45-53.
13. Chaki S, Okuyama S, Ogawa S, Tanaka M, Muramatsu M, Nakazato et al. Solubilization and characterization of binding sites for [3H]NE-100, a novel and potent sigma 1 ligand, from guinea pig brain. Life Sci 1996; 59:1331-1340.
14. Su TP, Wu XZ, Cone EJ, Shukla K, Gund TM et al. Sigma compounds derived from phencyclidine: identification of PRE-084, a new, selective sigma ligand. J Pharmacol Exp Ther 1991; 259:543-550.
15. 2+ channels in rat and mouse cultured, hippocampal pyramidal neurons. Br J Pharmacol 1995; 116:2801-2810.
16. Morin-Surun MP, Collin T, Denavit-Saubié M, Baulieu E-E, Monnet FP. Intracellular σ1 receptor modulates phospholipase C and protein kinase C activities in the brainstem. Proc Natl Acad Sci USA 1999; 96:8196-8199.
17. Ovalle S, Zamanillo D, Andreu F, Farre AJ, Guitart X. Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic. Eur J Neurosci 2001; 13:909-915.
18. Copani A, Bruno V, Battaglia G, Leanza G, Pellitteri R et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol 1995; 47:890-897.
19. Xie J, Guo Q, Zhu H, Wooten MW, Mattson MP. Protein kinase C iota protects neural cells against apoptosis induced by amyloid beta-peptide. Brain Res Mol Brain Res 2000; 82:107-113.
20. Mattson MP, Tomaselli KJ, Rydel RE. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res 1993; 621:35-49.
21. Maurice T. Improving Alzheimer's disease-related cognitive deficits with sigmal receptor agonists. Drug News Perspect 2002; 15:617-625.